Call: 080-40987695,96,97
Toll Free: 1-800-108-5011
Contact Us


Home »  Products » Anticoagulant  » Thrombonex-10 Tablets

Thrombonex-10 Tablets:

Rivaroxaban 10 mg

A new way to present thrombosis an oral direct factor Xa inhibitor that doesn't require routine coagulation monitoring.

A direct oral anticoagulant approved for the prevention of stroke and systemic embolism in patients wirh non valvular atrial fibrillation.

In a study involving 8000 patients with DVT and pulmonary embolism. Rivaroxaban was shown to be as effective as subcutaneous enoxaparin sodium.

Rivaroxaban is superior to warfarin and similar to dabigatran, apixaban and edoxaban for the prevention of stroke or embolism.

An effective therapy to prevent venous thromboembolism fibrillating total hip or knee replacement surgeries.

Compassable to warfarin in efficacy and safely energy morbidly obese patients with atrial fibrillation.


Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation

Reduction of risk of recurrence of deep vein thrombosis & pulmonary embolism 

Reduction of risk of major cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD)

Prophylaxis of deep vein thrombosis following hip or knee replacement surgery

Deep vein thrombosis

Pulmonary embolism


DVT for hip or knee replacement surgery

Stent 6-10 hrs after surgery once hemostasis has been established 10mg PO qday for 12 to 35 days.

Venous thromoembolism 

10mg PO qday in hospital and continue after hospital for 31 to 39 days.